XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 30, 2024
Dec. 30, 2023
Current assets:    
Cash and cash equivalents $ 327,039 $ 276,771
Trade receivables and contract assets, net of allowances for credit losses of $25,407 and $25,722, respectively 786,980 780,375
Inventories 361,281 380,259
Prepaid assets 93,834 87,879
Other current assets 99,054 83,378
Total current assets 1,668,188 1,608,662
Property, plant and equipment, net 1,618,708 1,639,741
Venture capital and strategic equity investments 243,543 243,811
Operating lease right-of-use assets, net 384,394 394,029
Goodwill 3,070,241 3,095,045
Intangible assets, net 827,638 864,051
Deferred tax assets 36,924 40,279
Other assets 303,147 309,383
Total assets 8,152,783 8,195,001
Current liabilities:    
Accounts payable 129,682 168,937
Accrued compensation 189,606 213,290
Deferred revenue 256,383 241,820
Accrued liabilities 190,892 227,825
Other current liabilities 188,247 203,210
Total current liabilities 954,810 1,055,082
Long-term debt, net and finance leases 2,660,459 2,647,147
Operating lease right-of-use liabilities 418,054 419,234
Deferred tax liabilities 180,094 191,349
Other long-term liabilities 235,441 223,191
Total liabilities 4,448,858 4,536,003
Commitments and contingencies (Notes 2, 11, 13, and 15)
Redeemable noncontrolling interest 57,775 56,722
Equity:    
Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 120,000 shares authorized; 51,552 shares issued and 51,510 shares outstanding as of March 30, 2024, and 51,338 shares issued and outstanding as of December 30, 2023 515 513
Additional paid-in capital 1,939,413 1,905,578
Retained earnings 1,959,777 1,887,218
Treasury stock, at cost, 42 and zero shares, as of March 30, 2024 and December 30, 2023, respectively (9,351) 0
Accumulated other comprehensive loss (249,919) (196,427)
Total Charles River Laboratories International, Inc. equity 3,640,435 3,596,882
Nonredeemable noncontrolling interests 5,715 5,394
Total equity 3,646,150 3,602,276
Total liabilities, noncontrolling interests and equity $ 8,152,783 $ 8,195,001